Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity
- DOI
- 10.1182/bloodadvances.2026021352
- Published
- 2026-09-24
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026021352,
title = {Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity},
author = {Vanja Zeremski and Jeong-Ok Lee and Robert Puckrin and Farah Yassine and Colin Stewart and Mehdi Hamadani and Tobias Ronny Haage and Louisa Adolph and Sina Alexandra Beer and Fabian Görke and Jens P. Panse and Jessica Schneider and Ulf Schnetzke and Vladan Vucinic and Jeanette Walter and Hanno M. Witte and Dimitrios Mougiakakos},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2026021352},
url = {https://doi.org/10.1182/bloodadvances.2026021352}
}RIS
TY - JOUR TI - Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity AU - Vanja Zeremski AU - Jeong-Ok Lee AU - Robert Puckrin AU - Farah Yassine AU - Colin Stewart AU - Mehdi Hamadani AU - Tobias Ronny Haage AU - Louisa Adolph AU - Sina Alexandra Beer AU - Fabian Görke AU - Jens P. Panse AU - Jessica Schneider AU - Ulf Schnetzke AU - Vladan Vucinic AU - Jeanette Walter AU - Hanno M. Witte AU - Dimitrios Mougiakakos PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2026021352 UR - https://doi.org/10.1182/bloodadvances.2026021352 ER -
APA
Zeremski, V., Lee, J., Puckrin, R., Yassine, F., Stewart, C., Hamadani, M., Haage, T. R., Adolph, L., Beer, S. A., Görke, F., Panse, J. P., Schneider, J., Schnetzke, U., Vucinic, V., Walter, J., Witte, H. M., & Mougiakakos, D. (2026). Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity. Blood Advances. https://doi.org/10.1182/bloodadvances.2026021352
Source records
- crossref · retrieved 2026-09-26T09:19:30.452Z